Is oral dydrogesterone equivalent to vaginal micronized progesterone for luteal phase support in women receiving oocyte donation?
Abstract Research question To determine whether the use of oral dydrogesterone (DYD) in luteal phase support (LPS) during an artificial cycle provides equivalent clinical and ongoing pregnancy, delivery and miscarriage rates as micronized vaginal progesterone (MVP) in oocyte donation recipients. Des...
Main Authors: | Margaux Lorillon, Geoffroy Robin, Laura Keller, Emeline Cailliau, Clémence Delcourt, Virginie Simon, Christine Decanter, Sophie Catteau-Jonard |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-12-01
|
Series: | Reproductive Biology and Endocrinology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12958-024-01322-7 |
Similar Items
-
Systematic use of long-acting intramuscular progesterone in addition to oral dydrogesterone as luteal phase support for single fresh blastocyst transfer: A pilot study
by: Virginie Simon, et al.
Published: (2022-12-01) -
Comparison of the effect of dydrogesterone and natural micronized progesterone for luteal‐phase support in assisted reproductive technology cycles: A single‐blind randomized clinical trial study
by: Masoomeh Atarieh, et al.
Published: (2024-08-01) -
A comparison of oral dydrogesterone with vaginal progesterone for luteal-phase support in in vitro fertilization: A randomized controlled trial
by: Elham Naghshineh, et al.
Published: (2023-01-01) -
Supplementary dydrogesterone is beneficial as luteal phase support in artificial frozen-thawed embryo transfer cycles compared to micronized progesterone alone
by: Angela Vidal, et al.
Published: (2023-03-01) -
The addition of dydrogesterone improves the outcomes of pregnant women with low progesterone levels when receiving vaginal progesterone alone as luteal support in HRT‐FET cycles
by: Rena Toriumi, et al.
Published: (2023-01-01)